Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

somatostatin analogue therapy

Known as: Somatostatin Analog Therapy, therapy, somatostatin analogue 
Endocrine drug therapy that uses analogs of somatostatin to treat neuroendocrine tumors.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Background Patients with advanced midgut neuroendocrine tumors who have had disease progression during first‐line somatostatin… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE In acromegaly, 25-50% of patients respond inadequately to conventional long-acting somatostatin analogue (SSA) therapy… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
We intended to identify the prognostic factors and the results of interventions on patients with liver metastatic midgut… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2007
2007
Although the molecular mechanisms underlying GH secreting pituitary tumor formation are not well understood, mutations in the… Expand
  • figure 1
Is this relevant?
2007
2007
BACKGROUND The prevalence of gallstones (GS) is increased in acromegaly and further increased by somatostatin analogue (SA… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
CONTEXT Primary treatment with depot octreotide and lanreotide induces tumor shrinkage in newly diagnosed patients with… Expand
Is this relevant?
Review
2004
Review
2004
On their plasma membranes, cells express receptor proteins with high affinity for regulatory peptides, such as somatostatin… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1999
1999
The currently available octapeptide somatostatin analogues octreotide (Sandostatin, Sandostatin LAR, Novartis, Basle, Switzerland… Expand
Is this relevant?
1994
1994
BACKGROUND/AIMS Previous studies have shown that secretory losses in patients with end jejunostomy syndrome (EJS) on home… Expand
Is this relevant?
1988
1988
Five pancreatic cutaneous fistulas were treated by subcutaneous administration of a long-acting synthetic analog of somatostatin… Expand
Is this relevant?